UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

Annals of neurology, 2015-05, Vol.77 (5), p.830-839

2015

Volltextzugriff (PDF)

A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study

Movement disorders, 2012-06, Vol.27 (7), p.913-916

2012

Volltextzugriff (PDF)

Acute Occlusions of Dual-Layer Carotid Stents After Endovascular Emergency Treatment of Tandem Lesions

Stroke (1970), 2017-08, Vol.48 (8), p.2171-2175

2017

Volltextzugriff (PDF)

Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota

NPJ Parkinson's Disease, 2019-11, Vol.5 (1), p.28-9, Article 28

2019

Volltextzugriff (PDF)

Diffusion Tensor Imaging in Idiopathic REM Sleep Behavior Disorder Reveals Microstructural Changes in the Brainstem, Substantia Nigra, Olfactory Region, and Other Brain Regions

Sleep (New York, N.Y.), 2010-06, Vol.33 (6), p.767-773

2010

Volltextzugriff (PDF)

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial

Genomics, proteomics & bioinformatics, 2022-04, Vol.20 (2), p.274-287

2022

Volltextzugriff (PDF)

Acute stroke treatment and outcome in the oldest old (90 years and older) at a tertiary care medical centre in Germany-a retrospective study showing safety and efficacy in this particular patient population

BMC geriatrics, 2021-10, Vol.21 (1), p.611-611, Article 611

2021

Volltextzugriff (PDF)

Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions

Parkinson's disease, 2019, Vol.2019, p.1-12

2019

Volltextzugriff (PDF)

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Parkinsonism & related disorders, 2016-11, Vol.32, p.66-72

2016

Volltextzugriff (PDF)

Association between Parkinson's disease and the faecal eukaryotic microbiota

NPJ Parkinson's Disease, 2021-11, Vol.7 (1), p.101-101, Article 101

2021

Volltextzugriff (PDF)

Is increased spinal nociception another hallmark for Parkinson’s disease?

Journal of neurology, 2017-03, Vol.264 (3), p.570-575

2017

Volltextzugriff (PDF)

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Parkinsonism & related disorders, 2018-05, Vol.50, p.104-107

2018

Volltextzugriff (PDF)

Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT

Movement disorders, 2008-03, Vol.23 (4), p.596-599

2008

Volltextzugriff (PDF)

Diabetes and Parkinson disease: A sweet spot?

Neurology, 2018-05, Vol.90 (19), p.869

2018

Volltextzugriff (PDF)

A punch in the gut – Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease

Parkinsonism & related disorders, 2019-03, Vol.60, p.43-45

2019

Volltextzugriff (PDF)

Reduced Gastric Contraction in Rapid‐Eye‐Movement Sleep Behavior Disorder and De Novo Parkinson's Disease

Movement disorders, 2024-01, Vol.39 (1), p.53-63

2024

Volltextzugriff (PDF)

Does REM sleep behavior disorder have the guts to be Parkinson disease?

Neurology, 2015-11, Vol.85 (20), p.1732

2015

Volltextzugriff (PDF)

Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease

Parkinsonism & related disorders, 2020-01, Vol.70, p.20-22

2020

Volltextzugriff (PDF)

Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons

Neuroscience, 2017-12, Vol.365, p.137-145

2017

Volltextzugriff (PDF)

Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?

Journal of neurology, 2011-06, Vol.258 (6), p.982-990

2011

Volltextzugriff (PDF)

Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?

Autoimmunity highlights, 2021-04, Vol.12 (1), p.7-7, Article 7

2021

Volltextzugriff (PDF)

Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment

Frontiers in neurology, 2020-10, Vol.11

2020

Volltextzugriff (PDF)

Transdermal Nicotine Treatment and Progression of Early Parkinson's Disease

NEJM evidence, 2023-09, Vol.2 (9), p.EVIDoa2200311

2023

Volltextzugriff (PDF)

Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test

Movement disorders, 2011-12, Vol.26 (14), p.2559-2563

2011

Volltextzugriff (PDF)

Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis

Neuro-endocrinology letters, 2013, Vol.34 (1), p.14-17

2013

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study

Acute Occlusions of Dual-Layer Carotid Stents After Endovascular Emergency Treatment of Tandem Lesions

Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota

Diffusion Tensor Imaging in Idiopathic REM Sleep Behavior Disorder Reveals Microstructural Changes in the Brainstem, Substantia Nigra, Olfactory Region, and Other Brain Regions

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial

Acute stroke treatment and outcome in the oldest old (90 years and older) at a tertiary care medical centre in Germany-a retrospective study showing safety and efficacy in this particular patient population

Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Association between Parkinson's disease and the faecal eukaryotic microbiota

Is increased spinal nociception another hallmark for Parkinson’s disease?

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT

Diabetes and Parkinson disease: A sweet spot?

A punch in the gut – Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease

Reduced Gastric Contraction in Rapid‐Eye‐Movement Sleep Behavior Disorder and De Novo Parkinson's Disease

Does REM sleep behavior disorder have the guts to be Parkinson disease?

Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease

Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons

Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?

Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?

Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment

Transdermal Nicotine Treatment and Progression of Early Parkinson's Disease

Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test

Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis

Suchergebnisse filtern